NCT07620444

Brief Summary

This is a single-center, comparative, observational study. Datasets will be collected from patients with pathologically confirmed colon cancer who undergo abdomen-pelvis enhanced spectral CT scan.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
5mo left

Started Jun 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Jun 2026Dec 2026

First Submitted

Initial submission to the registry

May 11, 2026

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

June 2, 2026

Status Verified

April 1, 2026

Enrollment Period

7 months

First QC Date

May 11, 2026

Last Update Submit

May 27, 2026

Conditions

Colon Cancer Patients

Keywords

Spectral Precise Image

Outcome Measures

Primary Outcomes (2)

  • subjective overall Image quality using 5-point Likert scale(1-5)

    Radiologist will evaluate the overall image quality using 5 Likert scale ranging from 1(poor) to 5 (Excellent)

    From the date of image reconstruction completion to the date of image evaluation completion, anticipated 3 Months.

  • Objective image quality

    The objective image quality is evaluated by measuring the CT value shown in the image.

    From the date reconstruction completion to the date of image evaluation completion, anticipated 3months.

Interventions

This is an observational studyDEVICE

This is an observational study

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with colon cancer aged 18.

You may qualify if:

  • Patients pathologically confirmed with colon cancer via endoscopic biopsy.
  • Patients who underwent preoperative abdominopelvic enhanced spectral CT.
  • Study participant with age ≥ 18 years old.
  • Study participants that have signed Informed Consent Form (ICF).

You may not qualify if:

  • The clinical data or pathological information is considered incomplete after evaluation by the investigator.
  • The investigator determined that poor image quality (e.g. obvious artifacts, missing critical scan layers) would not satisfy post-processing analysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Yat-sen cancer center

Guangzhou, Guangdong, China

Location

Central Study Contacts

Miao Chuan Xie

CONTACT

+8618903050011xiechm@sysucc.org.cn

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2026

First Posted

June 2, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

June 2, 2026

Record last verified: 2026-04

Locations

CN(1)